These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
261 related articles for article (PubMed ID: 18760507)
1. Early diagnostic accuracy and pathophysiologic relevance of an autopsy-confirmed Alzheimer's disease peripheral biomarker. Khan TK; Alkon DL Neurobiol Aging; 2010 Jun; 31(6):889-900. PubMed ID: 18760507 [TBL] [Abstract][Full Text] [Related]
2. An internally controlled peripheral biomarker for Alzheimer's disease: Erk1 and Erk2 responses to the inflammatory signal bradykinin. Khan TK; Alkon DL Proc Natl Acad Sci U S A; 2006 Aug; 103(35):13203-7. PubMed ID: 16920798 [TBL] [Abstract][Full Text] [Related]
3. Improved discrimination of autopsy-confirmed Alzheimer's disease (AD) from non-AD dementias using CSF P-tau(181P). Koopman K; Le Bastard N; Martin JJ; Nagels G; De Deyn PP; Engelborghs S Neurochem Int; 2009 Sep; 55(4):214-8. PubMed ID: 19524111 [TBL] [Abstract][Full Text] [Related]
4. Cerebrospinal fluid {beta}-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain. Tapiola T; Alafuzoff I; Herukka SK; Parkkinen L; Hartikainen P; Soininen H; Pirttilä T Arch Neurol; 2009 Mar; 66(3):382-9. PubMed ID: 19273758 [TBL] [Abstract][Full Text] [Related]
5. Diagnostic performance of a CSF-biomarker panel in autopsy-confirmed dementia. Engelborghs S; De Vreese K; Van de Casteele T; Vanderstichele H; Van Everbroeck B; Cras P; Martin JJ; Vanmechelen E; De Deyn PP Neurobiol Aging; 2008 Aug; 29(8):1143-59. PubMed ID: 17428581 [TBL] [Abstract][Full Text] [Related]
6. Alzheimer's disease: report of two autopsy cases with a clinical diagnosis of corticobasal degeneration. Okazaki K; Fu YJ; Nishihira Y; Endo M; Fukushima T; Ikeuchi T; Okamoto K; Onodera O; Nishizawa M; Takahashi H Neuropathology; 2010 Apr; 30(2):140-8. PubMed ID: 19780981 [TBL] [Abstract][Full Text] [Related]
7. Is aging part of Alzheimer's disease, or is Alzheimer's disease part of aging? Swerdlow RH Neurobiol Aging; 2007 Oct; 28(10):1465-80. PubMed ID: 16876913 [TBL] [Abstract][Full Text] [Related]
8. [Neuropathologic investigation in autopsies with special emphasis on findings in Alzheimer's disease]. Leel-Ossy L; Kindler M; Szucs I; Schwarcz T Ideggyogy Sz; 2006 May; 59(5-6):164-77. PubMed ID: 16786711 [TBL] [Abstract][Full Text] [Related]
9. High sensitivity analysis of amyloid-beta peptide composition in amyloid deposits from human and PS2APP mouse brain. Güntert A; Döbeli H; Bohrmann B Neuroscience; 2006 Dec; 143(2):461-75. PubMed ID: 17008022 [TBL] [Abstract][Full Text] [Related]
10. The impact of argyrophilic grain disease on the development of dementia and its relationship to concurrent Alzheimer's disease-related pathology. Thal DR; Schultz C; Botez G; Del Tredici K; Mrak RE; Griffin WS; Wiestler OD; Braak H; Ghebremedhin E Neuropathol Appl Neurobiol; 2005 Jun; 31(3):270-9. PubMed ID: 15885064 [TBL] [Abstract][Full Text] [Related]
11. CSF and MRI markers independently contribute to the diagnosis of Alzheimer's disease. Schoonenboom NS; van der Flier WM; Blankenstein MA; Bouwman FH; Van Kamp GJ; Barkhof F; Scheltens P Neurobiol Aging; 2008 May; 29(5):669-75. PubMed ID: 17208336 [TBL] [Abstract][Full Text] [Related]
12. Serum or cerebrospinal fluid levels of glyceraldehyde-derived advanced glycation end products (AGEs) may be a promising biomarker for early detection of Alzheimer's disease. Yamagishi S; Nakamura K; Inoue H; Kikuchi S; Takeuchi M Med Hypotheses; 2005; 64(6):1205-7. PubMed ID: 15823718 [TBL] [Abstract][Full Text] [Related]
13. PKCε deficits in Alzheimer's disease brains and skin fibroblasts. Khan TK; Sen A; Hongpaisan J; Lim CS; Nelson TJ; Alkon DL J Alzheimers Dis; 2015; 43(2):491-509. PubMed ID: 25125477 [TBL] [Abstract][Full Text] [Related]
15. Olfactory tau pathology in Alzheimer disease and mild cognitive impairment. Attems J; Jellinger KA Clin Neuropathol; 2006; 25(6):265-71. PubMed ID: 17140156 [TBL] [Abstract][Full Text] [Related]
16. The levels of soluble versus insoluble brain Abeta distinguish Alzheimer's disease from normal and pathologic aging. Wang J; Dickson DW; Trojanowski JQ; Lee VM Exp Neurol; 1999 Aug; 158(2):328-37. PubMed ID: 10415140 [TBL] [Abstract][Full Text] [Related]
17. A polymorphism in lipoprotein lipase affects the severity of Alzheimer's disease pathophysiology. Blain JF; Aumont N; Théroux L; Dea D; Poirier J Eur J Neurosci; 2006 Sep; 24(5):1245-51. PubMed ID: 16965549 [TBL] [Abstract][Full Text] [Related]
18. Circle of Willis atherosclerosis: association with Alzheimer's disease, neuritic plaques and neurofibrillary tangles. Beach TG; Wilson JR; Sue LI; Newell A; Poston M; Cisneros R; Pandya Y; Esh C; Connor DJ; Sabbagh M; Walker DG; Roher AE Acta Neuropathol; 2007 Jan; 113(1):13-21. PubMed ID: 17021755 [TBL] [Abstract][Full Text] [Related]